“The company faces a dilemma because the supply to Kofishield is greater than the demand and it has to cut production. We will complete the existing contract with the government next week. The company has written to the government for information on the amount ordered. , CEO Adar Poonawala He said that in an interview with CNBC-TV18.
SII currently produces approximately 250-275 million cans per month. Poonawala told TOI in an October interview that production would hit 240 million cans in November, up from around 220 million. TNN
“The serum contains 500 million doses and is waiting for the government to contact us.”
Previously, the company released around 100-110 million doses per month. In November, the company resumed exports from Covishield to Covax, a WHO-backed global platform, after ceasing in March when the country was hit by a second deadly wave of infections.
“If the government doesn’t need it, SII information will start exporting in the first quarter of 2021. We recently explained this to the government and we are discussing it, so I think we will wait a couple of days for them. to conduct internal discussions, ”added Poonawala, according to CNBC.-TV18.
The serum contains 500 million cans of Covishield – a semi-finished and semi-finished product, can be filled and refined in two months, has a shelf life of nine months – and is primarily available to the Indian government.
Given that Kofishield’s exports are also currently slowing, he said export orders will increase in the next quarter. “During the eight months we could not export, other countries were able to control the supply of donations from the United States and elsewhere, and we have lost much of their share,” he said, adding that he will now try to to regain demand in the US first quarter of next year.
“Writer. Extreme social media expert. Student. Typical reader. Friend of animals everywhere.”